Novo Nordisk to Cut 9,000 Jobs as Competition from Eli Lilly Squeezes Sales
Danish drugmaker behind Ozempic and Wegovy announces about 11% workforce reduction and a third profit warning as rivals gain ground
Danish drugmaker behind Ozempic and Wegovy announces about 11% workforce reduction and a third profit warning as rivals gain ground
Buy-now-pay-later firm lists at $40 and opens at $52, valuing it above £14 billion despite remaining below its 2021 peak
Former Bank of England governor warns higher borrowing costs and an increased debt burden leave the UK vulnerable if markets turn
Company cites insufficient UK investment and undervaluation of medicines; more than 100 jobs to be cut as government defends science funding
Producer prices unexpectedly fell and the dollar weakened, sending bullion to roughly $3,650 an ounce as investors and central banks pile into safe‑haven assets
Versailles-style, 25,700-square-foot estate in gated Rio Vista enclave closes after price reductions; buyer’s identity not disclosed

Majority of Unite members at London United accept offer; talks with London Transit continue while some routes remain at risk of disruption
Publisher cites mutual structure, dividend eligibility and age limits up to 90 while disclosing advertiser relationships and licensing for applications
Shares surge 30% on first day of trading as Swedish buy‑now, pay‑later firm raises $1.37 billion amid renewed appetite for tech listings